Status:
COMPLETED
Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer
Lead Sponsor:
Schiffler Cancer Center
Collaborating Sponsors:
Theragenics
University of Washington
Conditions:
Prostate Cancer
Eligibility:
MALE
40-80 years
Phase:
PHASE3
Brief Summary
The primary purpose of this study is to evaluate two treatment regimens for prostate cancer, prostate implant with 20 Gy of external beam radiation therapy versus prostate implant with 0 Gy of externa...
Detailed Description
Approximately 250,000 men are currently diagnosed with prostatic cancer in the United States each year. Of those, 70% have stage T1 or T2 disease (apparently limited to the prostate gland). Clinically...
Eligibility Criteria
Inclusion
- Patients with previously untreated prostatic cancer.
- Must have PSA 10-20 ng/ml, Gleason 7 to 9
Exclusion
- Patients with proven regional lymph node involvement will be excluded.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT00241384
Start Date
January 1 2005
End Date
November 1 2015
Last Update
November 17 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Veterans Administration Puget Sound Health Care System
Seattle, Washington, United States, 98108-1597
2
Schiffler Cancer Center
Wheeling, West Virginia, United States, 26003